ProPhase Labs, Inc. Equity Method Investment, Ownership Percentage
ProPhase Labs, Inc. (PRPH) had Equity Method Investment, Ownership Percentage of 50.00% as of 2019-12-31, per its 10-K filed 2020-03-26.
Discontinued › Notes › Investments
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2020-03-26
- 2019-12-31: Equity Method Investment, Ownership Percentage 50.00%.
- 2018-12-31: Equity Method Investment, Ownership Percentage 50.00%.
- 2017-12-31: Equity Method Investment, Ownership Percentage 50.00%.
- 2017-09-30: Equity Method Investment, Ownership Percentage 50.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2019-12-31 | 50.00% 10-K · filed 2020-03-26 |
| 2018-12-31 | 50.00% 10-K · filed 2019-03-26 |
| 2017-12-31 | 50.00% 10-K/A · filed 2018-08-20 |
| 2017-09-30 | 50.00% 10-Q/A · filed 2018-08-20 |
| 2017-06-30 | 50.00% 10-Q/A · filed 2018-08-20 |
| 2017-03-31 | 50.00% 10-Q/A · filed 2018-08-20 |
| 2016-12-31 | 50.00% 10-K · filed 2017-02-24 |
| 2016-09-30 | 50.00% 10-Q · filed 2016-11-14 |
| 2016-06-30 | 50.00% 10-Q · filed 2016-08-11 |
| 2016-03-31 | 50.00% 10-Q · filed 2016-05-13 |
| 2015-12-31 | 50.00% 10-K · filed 2016-03-29 |
| 2015-09-30 | 50.00% 10-Q · filed 2015-11-13 |
| 2015-06-30 | 50.00% 10-Q · filed 2015-08-12 |
| 2010-03-22 | 50.00% 10-K/A · filed 2018-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |